The 26 references in paper A. Karabaeva Zh., A. Essaian M., I. Kayukov G., А. Карабаева Ж., А. Есаян М., И. Каюков Г. (2008) “КАРДИОВАСКУЛЯРНЫЕ ЭФФЕКТЫ АЛЬДОСТЕРОНА // CARDIOVASCULAR EFFECTS OF ALDOSTERONE” / spz:neicon:nefr:y:2008:i:2:p:36-38

1
Christ M, Douwes K, Eisen C et al. Rapid non-genomic effects of aldosterone on sodium transport in rat vascular smooth muscle cells: involvement of the Na+/H+ antiport. Hypertension 1995; 25: 117-123
(check this in PDF content)
2
Camargo MJ, von Lutterotti N, Campbell JrWG et al. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens 1993;11:31- 40
(check this in PDF content)
3
Duprez D, de Buyzere M, Rietzchel ER, Clement DL. Aldosterone and vascular damage. Curr Hypertens Rep 2000; 2; 327-334
(check this in PDF content)
4
Epstein M. Aldosterone receptor blockade and the role of eplerenone: evolving perspectives. Nephrol Dial Transpl 2003; 18: 1984-1992
(check this in PDF content)
5
Foster RH, MacFarlane CH, Bustamante MO. Recent progress in understanding aldosterone secretion. Gen Pharmacol 1997; 28: 647- 651
(check this in PDF content)
6
Fuller PJ. Aldosterone’s effects and mechanism of action. Curr Opin Endocrinol Diabetes 1997; 4: 218-224
(check this in PDF content)
7
Ebata S, Muto S, Okada K et al. Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by non­ genomic and genomic mechanisms. Kidney Int 1999; 56: 1400­ 1412
(check this in PDF content)
8
Gekle M, Freudinger R, Mildenberger S, Silbernagl S. Rapid actions of aldosterone on cells from renal epithelium: the possible role of EGF-receptor signaling. Steroids 2002; 67: 499-504
(check this in PDF content)
9
Halimi J-M, Mimram A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995; 13: 1801-1802
(check this in PDF content)
10
Jalil JE, Janicki JS, Pick R, Weber KT. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: response to captopril. Am J Hypertens 1991; 4: 51-55
(check this in PDF content)
11
Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998; 93: 487-490
(check this in PDF content)
12
Laragh JH, Sealy JE. The renin-angiotensin-aldosterone system in hypertensive disorders: a key to two forms of arteriolar constriction and a possible clue to risk of vascular injury (heart attack and stroke) and prognosis. In: Laragh JH, Brenner BM (eds) Hypertension 1990; Pathophysiology, Diagnosis, and Management. Raven Press, New York, 1329-1348
(check this in PDF content)
13
Nishimura M, Uzu T, Fuji T et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261-266
(check this in PDF content)
14
Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709-717
(check this in PDF content)
15
Rossi GP, Sachetto A, Visentin P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-1045
(check this in PDF content)
16
Rocha R, Martin-Berger CL, Yang P et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 2002; 143: 4828-4836
(check this in PDF content)
17
Stier Jr CT, Chander PN, Gutstein WH et al. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 1991; 4: 680-687
(check this in PDF content)
18
Stier Jr CT, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens 1993; 11 [Suppl 3]: S37-S42
(check this in PDF content)
19
Silvestre J-S, Heymes C, Oubenaisso A et al. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999; 99: 2694-2701
(check this in PDF content)
20
Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II reseptors in the rat. Can J Physiol Pharmacol 1985; 63: 1522-1527
(check this in PDF content)
21
Takeda R, Matsubara T, Miyamori I et al. Research Committee of Disorders of Adrenal Hormones in Japan. Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 1995; 18: 370-373
(check this in PDF content)
22
Wehling M. Non-genomic actions of steroid hormones. Trends Endocrinol Metab 1994; 5: 347-353
(check this in PDF content)
23
Wehling M, Neylon CB, Fullerton M et al. Non-genomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res 1995; 76: 973-979
(check this in PDF content)
24
Wehling M, Spes CH, Win N et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998; 83: 3517-3522
(check this in PDF content)
25
Rocha R, Stier CTJ, Kifor I et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141: 3871-3878
(check this in PDF content)
26
Connell JMC, Davies E. The new biology of aldosterone. Journal of Endocrinology 2005; 186: 1-20 Поступила в редакцию 15.01.2008 г. Принята в печать 17.04.2008 г. 38
(check this in PDF content)